Pro-oxidant malonaldehyde and antioxidant ceruloplasmin levels in hypertrophic cardiomyopathy
Reena, T.R.; Annapurna, S.D.; Ushasree, B.; Pratibha, N.; Narasimhan, C.; Soma, R.
Indian Heart Journal 56(1): 72
2004
ISSN/ISBN: 0019-4832 PMID: 15129799 Document Number: 570539
Document emailed within 1 workday
Related Documents
Volchegorskiĭ, I.A.; Shaposhnik, I.I.; Alekseev, E.N.; Kharchenkova, N.V. 2002: Levels of lipid peroxidation products and ceruloplasmin in blood as characteristics of tolerance to physical load in hypertrophic cardiomyopathy Klinicheskaia Laboratornaia Diagnostika 2: 11-13Cardim, N. 1999: Dealing with a special group: hypertrophic cardiomyopathy. Models of diastolic dysfunction in hypertrophic cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(Suppl 5): V45-V46
Petlevski, R.; Zuntar, I.; Dodig, S.; Turkalj, M.; Cepelak, I.; Vojvodić, J.; Sicaja, M.; Missoni, S. 2009: Malonaldehyde and erythrocyte antioxidant status in children with controlled asthma Collegium Antropologicum 33(4): 1251-1254
Riedlbauchová, L.; Janoušek, J.; Veselka, J. 2013: Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy? Journal of Invasive Cardiology 25(6): E128-E132
Faludi, Réka.; Tóth, L.; Pótó, László.; Cziráki, A.; Simor, Tás.; Papp, L. 2005: Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy Orvosi Hetilap 146(1): 23-26
Thies, W.R.; Vyska, K.; Matthies, W.; Notohamiprodjo, G.; Knapp, W.; Meyer, H. 1989: Changes in fatty acid metabolism in dilated cardiomyopathy and hypertrophic cardiomyopathy in childhood Wiener Klinische Wochenschrift 101(1): 8-11
Shaposhnik, I.I.; Shaposhnik, O.D. 1992: The development of signs of dilated cardiomyopathy in patients with nonobstructive hypertrophic cardiomyopathy Terapevticheskii Arkhiv 64(11): 125-126
Cecchi, F.; Olivotto, I.; Lazzeroni, E.; Chiriatti, G.; Sachero, A.; Beretta, L.; Giagnoni, E.; Renosto, G.; Montereggi, A.; Baldassarre, S.; Castelli, G.; Ciaccheri, M. 1997: Clinical course of hypertrophic cardiomyopathy in a non selected population. the Experience of the Italian Multicenter Cardiomyopathy Study Giornale Italiano di Cardiologia 27(11): 1133-1143
Lin, Y.T.; Wu, M.H.; Wang, J.K.; Lue, H.C. 1998: Evolution of dilated cardiomyopathy from hypertrophic obstructive cardiomyopathy in a child Journal of the Formosan Medical Association 97(6): 416-419
Waśniewska, M.; Pacocha, W.; Kapuściński, O. 1976: Clinical manifestations, hemodynamic disorders and radiographic changes in primary cardiomyopathy. I. Hypertrophic cardiomyopathy with stenosis of the left ventricular outflow Kardiologia Polska 19(1): 33-38
Joanny, P.; Corriol, J.; Calcet, J.; Giannellini, F. 1971: Hyperbaric oxygen: malonaldehyde levels in the plasma, erythrocytes and cerebral tissue in rats Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(6): 1341-1346
Aycicek, A.; Erel, O. 2007: Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy Jornal de Pediatria 83(4): 319-322
Karabulut, A.B.; Kafkas, M.E.; Kafkas, A.S.; Onal, Y.; Kiran, T.R. 2013: The effect of regular exercise and massage on oxidant and antioxidant parameters Indian Journal of Physiology and Pharmacology 57(4): 378-383
Venkateshwari, A.; Nallari, P.; Vidyasagar, A.; Prasad, R.; Murty, J.S. 1997: Ceruloplasmin as an antioxidant in duodenal ulcers Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 16(3): 117
Abdullah, A.; Ssefer, V.; Ertugrul, U.; Osman, E.; Esref, A.; Ugur, C.M.; Adalet, A.; Yavuz, Y.; Faysal, E.; Nebahat, T. 2013: Evaluation of serum oxidant/antioxidant balance in patients with acute stroke JPMA. Journal of the Pakistan Medical Association 63(5): 590-593
Zinchuk, V.V.; Khodosovskiĭ, M.N.; Dremza, I.K. 2002: Blood oxygen transport and pro-oxidant-antioxidant state during liver reperfusion Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 8-11
Molina-Arjona, J.A.; de Bustos, F.; Benito-León, J.; Jiménez-Jiménez, F.J.; Rodríguez, J.; Trincado, R.; Porta-Etessan, J.; Vega, S.; Bermejo, F. 1999: Serum pro-oxidant and antioxidant factors and risk of Parkinson's disease: population study Revista de Neurologia 29(1): 12-15
Lakhin, R.E.; Belozerova, L.A.; Maksimets, V.A.; Romanov, D.M. 1999: Changes in the oxidant-antioxidant system activity in patients with hepatic failure treated with hyperbaric oxygenation and actoprotectors Anesteziologiia i Reanimatologiia 1999(2): 55-58
Demling, R.; Daryani, R.; Campbell, C.; Knox, J.; Youn, Y.K.; Lalonde, C. 1993: The effect of acute nonbacterial dependent peritonitis on lung and liver oxidant stress and antioxidant activity Surgery 114(3): 571-578
Timchenko, N.F.; Dolmatova, L.S.; Raznik, S.D.; Nedashkovskaia, E.P. 1998: Effect of the thermostable toxin of Yersinia pseudotuberculosis on the oxidant and antioxidant activity of human blood leukocytes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 16-20